Navigation Links
Clinical Update - Debio 025 in Hepatitis C
Date:1/26/2009

n, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed three products with global combined sales in excess of $2.65 billion in 2007.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com.

    Debiopharm Group Contact
    Maurice Wagner
    Director Corporate Affairs & Communications
    Tel.: +41(0)21-321-01-11
    Fax: +41(0)21-321-01-69
    mwagner@debiopharm.com

    Additional Media Contacts
    In London
    Maitland
    Brian Hudspith
    Tel: +44(0)20-7379-5151
    bhudspith@maitland.co.uk

    In New York
    Russo Partners, LLC
    Wendy Lau
    Tel: +1-212-845-4272
    Fax: +1-212-845-4260
    wendy.lau@russopartnersllc.com


'/>"/>
SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Health Minister Rona Ambrose today announced that ... $2.5 million in personal protective equipment (PPE) to the World ... the Ebola outbreak in West Africa . ... in the affected countries and has appealed to member states ... countries. Personal protective equipment such as respirator ...
(Date:9/15/2014)... Sept. 15, 2014  Alere Inc. (NYSE: ALR ... infectious disease, toxicology, cardiology and diabetes products and services, ... by former CEO Ron Zwanziger , filed a ... subsequently sent a letter to Gregg J. Powers ... due diligence in an effort to secure financing to ...
(Date:9/15/2014)... , Sept. 15, 2014  Patients in today,s changing ... more frequently in an outpatient setting versus a hospital. ... and to ensure that patients continue to receive high ... launch of its new internal medicine residency program. The ... often in office, clinic and even virtual settings. ...
Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Alere Responds To Letter From Former Executives 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3
... 2011 Hospira, Inc. (NYSE: HSP ... technologies, today reported results for the third quarter ended Sept. ... and adjusted* diluted earnings per share were $0.66. (Adjusted* measures ... release and the attached schedules.) "As we indicated ...
... NEW YORK, Oct. 26, 2011 Reportlinker.com ... is available in its catalogue: ... Worldwide, 2009 to 2015 ... study has 484 pages, 235 tables and ...
Cached Medicine Technology:Hospira Reports Third-Quarter 2011 Results 2Hospira Reports Third-Quarter 2011 Results 3Hospira Reports Third-Quarter 2011 Results 4Hospira Reports Third-Quarter 2011 Results 5Hospira Reports Third-Quarter 2011 Results 6Hospira Reports Third-Quarter 2011 Results 7Hospira Reports Third-Quarter 2011 Results 8Hospira Reports Third-Quarter 2011 Results 9Hospira Reports Third-Quarter 2011 Results 10Hospira Reports Third-Quarter 2011 Results 11Hospira Reports Third-Quarter 2011 Results 12Hospira Reports Third-Quarter 2011 Results 13Hospira Reports Third-Quarter 2011 Results 14Hospira Reports Third-Quarter 2011 Results 15Hospira Reports Third-Quarter 2011 Results 16Hospira Reports Third-Quarter 2011 Results 17Hospira Reports Third-Quarter 2011 Results 18Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 2Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 3Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 4Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 5Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 6Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 7Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 8Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 9Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 10Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 11Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 12Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 13Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 14Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 15Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 16Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 17Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 18Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 19
(Date:9/16/2014)... Francisco, September 15, 2014Prostate cancer patients who received ... quality of life, as well as bladder and ... after RT, according to research presented today at ... Annual Meeting. Additionally, results indicate that parallel quality ... who receive different regimens of HPFX RT. , ...
(Date:9/16/2014)... who have had children (parous women) appear to ... breast cancer, the subtype that carries a higher ... of African ancestry. A similar relationship was ... between childbearing and increased risk of estrogen receptor-negative ... the women who had never breastfed. These findings, ...
(Date:9/16/2014)... better predict a man,s risk of getting prostate cancer ... largest-ever analysis of the cancer,s genetic biomarkers, reported in ... Health and Biomedical Innovation,s Dr Jyotsna Batra and Distinguished ... the large consortia of research hubs around the world, ... markers in 80,000 men. , "It,s the largest analysis ...
(Date:9/16/2014)... Definitive Healthcare , the ... providers, is pleased to announce the release of ... now available for subscription, features detailed hospital profiles ... affiliations. , The Canadian database spans Canada’s ten ... over 750 hospitals. Each hospital profile provides ...
(Date:9/16/2014)... 16, 2014 Gary F. Locke, the ... has selected Worldwide Speakers Group for exclusive representation of ... of Commerce and Governor of Washington, Locke is widely ... U.S.-China relations, global expansion, and business growth. , “Gary ... and how to grow an organization’s global presence in ...
Breaking Medicine News(10 mins):Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 2Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 3Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2Health News:New gene research helps pinpoint prostate cancer risk 2Health News:Canadian Hospital Database Now Offered by Definitive Healthcare 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2
... of inappropriate shocks from appliances have been reported ... literally shocking tale of the potential dangers of ... comes from cardiologists in Denmark. , "We recently ... implantable cardioverter defibrillator, was readmitted shortly after hospital ...
... Bipartisan Group Led by Former Rep. Gephardt Underscores ... Finding Cures for Life-Threatening Diseases , WASHINGTON, March ... applauds President Obama on his support for improving ... costs through continued scientific and technological advancements. (Logo: ...
... prevents Honolulu residents from implementing ... 25 Taking Control of Your Diabetes (TCOYD) announced ... research firm Yankelovich that found that although Honolulu residents ... about diabetes management than the majority of their peers ...
... N.J., March 25 The Christopher & Dana Reeve ... and treatments for spinal cord injuries and improving the ... States House of Representatives for passing the Christopher and ... 146, the Omnibus Public Land Management Act. The legislation ...
... reports a more powerful immune response than from an injection ... nicer it would be to get vaccinated by drinking a ... , That might someday be the case, thanks to Northwestern ... which are healthy bacteria found in dairy products such as ...
... Data provided by nonprofit organization, Consumers, CheckbookMILWAUKEE, March ... the world,s largest-circulation magazine with more than ... map listing the top-ranked hospitals in the U.S. ... Luke,s Medical Center was one of two ...
Cached Medicine News:Health News:Faulty Household Wiring Can Trigger a Heart Defibrillator 2Health News:Council for American Medical Innovation Applauds President Obama for Calling for 'Serious Investments in Science and Technology' 2Health News:Survey Reveals Honolulu Residents Perceive Financial Challenges as Main Barrier in Properly Managing Their Type 2 Diabetes 2Health News:Survey Reveals Honolulu Residents Perceive Financial Challenges as Main Barrier in Properly Managing Their Type 2 Diabetes 3Health News:Survey Reveals Honolulu Residents Perceive Financial Challenges as Main Barrier in Properly Managing Their Type 2 Diabetes 4Health News:Christopher & Dana Reeve Foundation Applauds Historic Passage of the Christopher and Dana Reeve Paralysis Act 2Health News:Christopher & Dana Reeve Foundation Applauds Historic Passage of the Christopher and Dana Reeve Paralysis Act 3Health News:Oral Yogurt 'Vaccine' Could Blunt Ouch Factor 2Health News:AARP Magazine Lists Aurora St. Luke's Medical Center Among the 126 Best Hospitals in the United States 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: